Browse by People

Panzuto, Francesco, Ramage, John, Pritchard, D Mark ORCID: 0000-0001-7971-3561, van Velthuysen, Marie-Louise F, Schrader, Joerg, Begum, Nehara, Sundin, Anders, Falconi, Massimo and O'Toole, Dermot (2023) European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. JOURNAL OF NEUROENDOCRINOLOGY, 35 (8). e13306-.

Collapse authors list.
Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Barriuso, Jorge, Lamarca, Angela, Manoharan, Prakash, Westwood, Thomas, Jaffa, Matthew, Fenwick, Stephen W, Nuttall, Christina, Lalloo, Fiona, Prachalias, Andreas et al (show 12 more authors) , Pizanias, Michail, Wieshmann, Hulya, McNamara, Mairead G, Hubner, Richard, Srirajaskanthan, Raj, Vivian, Gillian, Ramage, John, Weickert, Martin O, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Vinjamuri, Sobhan, Valle, Juan and Yip, Vincent S (2021) The Impact of <SUP>68</SUP>Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours. FRONTIERS IN ENDOCRINOLOGY, 12. 654975-.

Collapse authors list.
Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari et al (show 11 more authors) , Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S, Hobbs, Claire, Barber, Safia, Ryder, W David, Ramage, John, Davies, Linda M, Bridgewater, John A and Valle, Juan W (2021) Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. LANCET ONCOLOGY, 22 (5). pp. 690-701.